A detailed history of Essex Woodlands Management, Inc. transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Essex Woodlands Management, Inc. holds 1,551,521 shares of EYPT stock, worth $12.5 Million. This represents 4.41% of its overall portfolio holdings.

Number of Shares
1,551,521
Previous 1,551,521 -0.0%
Holding current value
$12.5 Million
Previous $32.1 Million 57.91%
% of portfolio
4.41%
Previous 9.32%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$19.93 - $29.71 $15.7 Million - $23.4 Million
-786,265 Reduced 33.63%
1,551,521 $32.1 Million
Q4 2023

Feb 14, 2024

SELL
$5.71 - $24.13 $6.58 Million - $27.8 Million
-1,153,135 Reduced 33.03%
2,337,786 $54 Million
Q3 2023

Nov 14, 2023

SELL
$7.99 - $15.36 $5.59 Million - $10.8 Million
-700,000 Reduced 16.7%
3,490,921 $27.9 Million
Q4 2020

Feb 12, 2021

BUY
$3.7 - $6.58 $15.5 Million - $27.6 Million
4,190,921 New
4,190,921 $27.6 Million

Others Institutions Holding EYPT

About EyePoint Pharmaceuticals, Inc.


  • Ticker EYPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,072,200
  • Market Cap $275M
  • Description
  • EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...
More about EYPT
Track This Portfolio

Track Essex Woodlands Management, Inc. Portfolio

Follow Essex Woodlands Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Woodlands Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Essex Woodlands Management, Inc. with notifications on news.